An analysis of 32 primary HCC tissues collected from patients admitted to the Hospital of Guangdong between May 2019 and November 2020 revealed that PD-L1-positive patients had lower TMB, greater vascular invasion and more advanced BCLC stages than PD-L1-negative patients [44]. This evidence concerns the gene CD274 and hepatocellular carcinoma.